Scientists launch first human tests of new diabetes drug
NCT ID NCT06324604
Summary
This is the first study in humans of an experimental drug called MTX-101. Researchers are testing it first in healthy adults and then in people with type 1 diabetes to understand its safety, how long it stays in the body, and how it affects specific immune cells. The main goal is to gather initial safety data and see how the body processes the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Austin Health
RECRUITINGHeidelberg, Victoria, 3084, Australia
Contact
-
St Vincent's Hospital Melbourne (SVHM)
RECRUITINGMelbourne, Victoria, Austria
Contact
-
The Royal Melbourne Hospital
RECRUITINGMelbourne, Victoria, 3050, Australia
Contact
-
Wesley Research Institute
ACTIVE_NOT_RECRUITINGAuchenflower, Queensland, 4066, Australia
Conditions
Explore the condition pages connected to this study.